5 - Older Adults, Pediatrics, and Gestational DM

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/79

encourage image

There's no tags or description

Looks like no tags are added yet.

80 Terms

1
New cards

What are key considerations for diabetes in older adults?

29% of adults over 65 have diabetes.

Increased cognitive decline, disability, mobility issues, and muscle loss

More comorbidities (HTN, CKD, CAD)

Use individualized, age-friendly care with the 4Ms framework → Matter, Meds, Mentation, Mobility

2
New cards

What is the standard screening for diabetes in older adults?

Fasting plasma glucose and/or A1c

May consider 2-hour oral glucose tolerance test if patient meets criteria for prediabetes

3
New cards

What are the limitations for standard screening for diabetes in older adults?

Older adults tend to have postprandial vs fasting hyperglycemia

Comorbidities can impact the lifespan of red blood cells in circulation

A1c does not identify hypoglycemia patterns → 75% of those with an elevated A1c experienced a glucose level < 60 mg/dL

4
New cards

Glycemic goals for healthy older adults?

Few comorbidities & Intact cognitive function → Longer life expectancy

A1c goal → <7-7.5%

Fasting or preprandial glucose → 80-130 mg/dL

Bedtime glucose → 80-180 mg/dL

5
New cards

Glycemic goals for complex/intermediate older adults?

Multiple comorbidities & mild/moderate cognitive impairment → variable life expectancy, consider fall/hypoglycemia risk

A1c goal → <8%

Fasting or preprandial glucose → 90-150 mg/dL

Bedtime glucose → 100-180 mg/dL

6
New cards

Glycemic goals for very complex/poor health older adults?

LTC, end-stage illness, dementia → limited remaining life expectancy

A1c goal → Avoid reliance on A1c

Fasting or preprandial glucose → 100-180 mg/dL

Bedtime glucose → 110-200 mg/dL

7
New cards

Continuous glucose monitoring in older adults?

May improve glycemic outcomes and reduce hypoglycemia in older adults with type 2 diabetes → including those not treated with insulin

8
New cards

Why are older adults at higher risk for hypoglycemia?

Irregular meal intake

Worsening kidney function

Insulin deficiency/need for insulin therapy

9
New cards

How does risk for unidentified cognitive impairment in older adults effect their diabetes?

Causes difficulty performing self-care activities like insulin administration and/or glucose monitoring

10
New cards

What are key pharmacological considerations in older adults?

Choose meds with low hypoglycemia risk

Simplify regimens; reduce treatment burden and polypharmacy

Consider comorbidities and heart/kidney benefits

Consider cost, Medicare, deductibles, and fixed incomes

11
New cards

Metformin?

$

First line for older adults

Monitor renal function closely (eGFR)

GI side effects (nausea, diarrhea)

Long term use → consider monitoring for vitamin B12 deficiency

12
New cards

Insulin?

$$

Daily basal injection (well tolerated)

Multiple injections/bolus (complex; risk of hypoglycemia)

Injection technique

13
New cards

DPP-4 inhibitors?

$$$

Low risk of hypoglycemia

No cardiovascular or renal benefits

14
New cards

SGLT2 inhibitors?

Cardiovascular & renal benefits

Side effects (volume depletion, UTI, urinary incontinence, euglycemic DKA)

15
New cards

GLP-1/GIP agonists?

$

Cardiovascular & renal benefits

Injection technique/weekly dosing/slow titration

Side effect profile (risk of weight loss, GI side effects)

16
New cards

Which antihyperglycemics to avoid in older adults?

Sulfonylureas

Thiazolidinediones (TZDs)

17
New cards

Why avoid Sulfonylureas in older adults?

Hypoglycemia, fracture risk

Antimicrobial drug-drug interactions (increase effective SU dose)

Requires consistent, adequate eating patterns

Glipizide (short duration of action) > Glyburide

18
New cards

Why avoid TZDs in older adults?

Risk of heart failure

Fluid retention

Weight gain

Osteoporosis

Risk of falls and/or fractures

Macular edema

19
New cards

Basal insulin regimen in older adults?

Administer in the morning

Pick long-acting vs. NPH insulin (lower risk of hypoglycemia)

20
New cards

Prandial / Mealtime insulin require <10 units/dose in older adults?

Stop insulin & add noninsulin agent → i.e. metformin

21
New cards

Prandial / Mealtime insulin require >10 units/dose in older adults?

Decrease insulin dose by 50% & then add noninsulin agent

Titrate prandial insulin down as noninsulin agent dose is titrated up

Goal → discontinue prandial insulin

22
New cards

Pre-mixed insuli nregimens for older adults?

Use 70% of total daily dose as basal insulin (in morning)

23
New cards

Mentation in the 4Ms framework for older adults?

Hyperglycemia and hypoglycemia are associated with cognitive decline, which can make it difficult to perform complex self-care tasks

24
New cards

Mobility in the 4Ms framework for older adults?

Dexterity & vision changes impact diabetic regimen

25
New cards

Medications in the 4Ms framework for older adults?

There is a need to establish a balance between treating comorbidities while also minimizing polypharmacy

It’s important to also consider de-intensifying the diabetes regimen to lower risk of hypoglycemia and/or minimize treatment burden

26
New cards

What matters most regarding the 4M framework?

It’s important to optimize treatment goals based on life expectancy

A main goal will always be to avoid hypoglycemia & symptomatic hyperglycemia

27
New cards

Blood pressure goal in Healthy and Complex/Intermediate older adults?

<130/80 mmHg

28
New cards

Blood pressure goal in very complex/poor health older adults?

<140/90 mmHg

29
New cards

Primary preventions of dyslipidemia in adults 40-75 with no ASCVD risks?

Statin intensity → moderate

30
New cards

Primary preventions of dyslipidemia in adults 40-75 with ASCVD risks?

1 or more ASCVD risk factor

Statin intensity → high

31
New cards

Secondary prevention of dyslipidemia?

In all ages →

ASCVD
Statin intensity → high

32
New cards

What is Type 1 diabetes?

Most common form of diabetes among children/adolescents

Autoimmune destruction of pancreatic β-cells

Causes absolute insulin deficiency

Insulin is the mainstay of treatment

Increased risk of other autoimmune disorders

33
New cards

How is Type 1 diabetes screened in youth?

Screen around ages 7–8 using islet autoantibodies

Screen earlier if symptoms are present

34
New cards

How does Type 1 diabetes commonly present, and how is it diagnosed?

Common symptoms → polyuria and polydipsia

50% present with DKA

Increased risk of disordered eating

Diagnosis → symptoms + random plasma glucose ≥200 mg/dL

Avoid A1c for diagnosis

35
New cards

How are glycemic goals individualized for T1D?

Blood glucose → modify if frequent hypoglycemia or hypoglycemia unawareness

A1c → reassess over time

36
New cards

How often should glucose be monitored for T1D?

Multiple times daily (up to 10x/day)

With blood glucometer or CGM

Prior to food → at bedtime

As needed for safety

37
New cards

Glycemic goals for T1D?

A1c → <7%

Preprandial → 80-130 mg/dL

Bedtime/Overnight → 90-150 mg/dL

CGM time in range (TIR) → 70-180 mg/dL

38
New cards

What is the typical starting insulin dose for youth with T1D?

0.5 units/kg/day

Range → 0.4–1 unit/kg/day

Consider puberty, menses, and illness

39
New cards

How is the total daily dose (TDD) divided between basal and bolus insulin?

50% basal

50% prandial (bolus)

May vary with carbohydrate intake, age, and puberty stage

40
New cards

When should prandial (mealtime) insulin ideally be administered?

Before meal consumption

41
New cards

What factors affect prandial insulin dosing and mealtime corrections?

Nutritional intake

Preprandial blood glucose

Anticipated physical activity

42
New cards

What factors should healthcare providers consider when managing insulin in youth with T1D?

Changes in insulin sensitivity (growth and sexual maturity)

Ability to provide self-care

Supervision at daycare or school

Neurocognitive effects of hypoglycemia and hyperglycemia (including DKA)

43
New cards

How is the prevalence of T2D in youth expected to change?

Expected to quadruple (4x) in the next 40 years among those under 20

Disproportionately impacts historically marginalized communities

44
New cards

When should screening for T2D in youth be considered?

After puberty or ≥10 years old

45
New cards

What criteria are needed to screen youth for T2D?

Overweight and/or obese

PLUS ≥1 risk factor

46
New cards

What are risk factors for T2D in youth?

Physical inactivity

First-degree relative with diabetes

High-risk race/ethnicity/ancestry

Female sex

Hypertension

47
New cards

What tests can be used to diagnose T2D in youth?

Fasting plasma glucose

2-hour OGTT

Random elevated glucose with hyperglycemia symptoms

A1c

48
New cards

What should be avoided when diagnosing T2D?

Using A1c alone

49
New cards

If youth T2D is suspected, what additional testing should be done and why?

Pancreatic autoantibody panel

Excludes possible Type 1 diabetes

50
New cards

Glycemic goals for youth with T2D?

A1c goal → <6.5%

Lower A1c goal than T1D → lower risk of hypoglycemic and higher risk of complications

Preprandial goal → 80-130 mg/dL

2-Hour Postprandial → <180 mg/dL

51
New cards

What are the goals of lifestyle interventions in youth T2D?

Developmentally and culturally appropriate

7–10% decrease in excess weight

52
New cards

What is the recommended daily physical activity for youth T2D?

60 minutes of moderate-to-vigorous activity

Reduce sedentary recreational screen time

53
New cards

What foods should be INCREASED in youth T2D?

Nonstarchy vegetables

Whole fruits and whole grains

Low-fat dairy

Legumes, nuts, and seeds

54
New cards

What foods should be DECREASED?

Meat

Refined grains

Ultra-processed foods

Sugar-sweetened beverages

55
New cards

Ac1 <8.5% in youth T2D?

No acidosis or ketosis

Metformin titrated up to 2000mg daily as tolerated

56
New cards

Ac1 >8.5 in youth T2D?

No acidosis or ketosis

Metformin PLUS
Long-acting insulin → start at 0.5 units/kg/day and tirate every 2-3 days based on blood glucose

57
New cards

What if A1c goals are not met in youth T2D?

Continue metformin

Consider adding GLp1 agonist or SGLT2i → >10 years old

If only on long acting insulin add prandial insulin

Prioritize and maximize noninsulin medications before insulin changes

58
New cards

Hypertension management in youth with diabetes?

Blood pressure (BP) should be measured at every routine visit

Goal BP

  • <90th percentile for age/sex/height

-OR-

  • If ≥ 13 years old, <130/80mmHg

Diagnosis → 3 separate BP measurements above goal

Treatment → #1 = Lifestyle Interventions #2 = Add ACE Inhibitor or ARB*

59
New cards

Dyslipidemia management in youth with diabetes?

An initial lipid panel should be completed soon after diagnosis of diabetes**

Goal → LDL < 100 mg/dL

When to Retest → If initial LDL ≤ 100 mg/dL, then test again between 9-11 years old, must be fasting lipid panel

Treatment →

  • LIFESTYLE INTERVENTIONS

  • If LDL > 100 mg/dL, treat with medical nutrition therapy (i.e. low- fat diet)

  • If LDL remains ≥ 130 mg/dL, then consider adding statin


60
New cards

Preexisting diabetes?

Women with a diagnosis of T1 or T2 before pregnancy

61
New cards

Gestational diabetes?

Women without a diagnosis of diabetes before pregnancy

Diagnosed during second or third trimester of pregnancy

Screened at 24-28 weeks of gestation if not previously found to have diabetes

62
New cards

What is GDM prevalence worldwide, and how can maternal hyperglycemia affect the child?

~14% of pregnancies worldwide

Increases child's future risk of obesity, hypertension, and T2D

63
New cards

Maternal risks for GDM?

During Pregnancy → Spontaneous abortion or Preeclampsia

Long-term type II diabetes

64
New cards

Fetal risks for GDM?

In Utero/Development → Fetal anomalies, Large birth weight

Neonatal → Hypoglycemia, Hyperbilirubinemia, Respiratory distress syndrome

65
New cards

Screening and risk assessment in GDM?

Overweight/obese

Polycystic ovarian syndrome

Family history of diabetes

Previous history of GDM

Presence of glucosuria

If considered high risk → screen for GDM asap

66
New cards

What test is used to screen for GDM at 24–28 weeks?

75-g OGT

Check glucose at fasting, 1 hour, and 2 hours

67
New cards

How often should blood glucose be monitored in GDM?

Ideally 2–4 times daily

68
New cards

How do glycemic goals in GDM differ from preexisting diabetes?

Goals differ based on GDM vs. preexisting diabetes

Also depend on insulin use vs. no insulin

Less stringent goals if significant hypoglycemia occurs

69
New cards

What is the role of A1c in monitoring GDM?

Secondary measurement after blood glucose monitoring

70
New cards

Glycemic goals for GDM?

Fasting → 70-95 mg/dL

1-Hour Post Prandial → 110-140 mg/dL

2-Hours post prandial → 100-120 mg/dL

71
New cards

What happens to insulin sensitivity and requirements during early pregnancy?

Increased insulin sensitivity → lower glucose levels

Decreased insulin requirements

Increased hypoglycemia risk in T1D if insulin isn't adjusted

72
New cards

What happens to insulin requirements during the 2nd and 3rd trimesters?

Rapidly progressive insulin resistance

Increased total daily insulin requirements (~5%)

73
New cards

How do insulin requirements change at the end of pregnancy and after delivery?

End of 3rd trimester: insulin requirements level off

After placenta delivery: insulin resistance dramatically decreases

Reevaluate and adjust insulin requirements

74
New cards

What is the 1# treatment of diabetes in pregnancy?

Start first trimester or early second trimester

Medical nutrition therapy

Physical activity (150 min/week moderate intensity aerobic activity)

Weight management

75
New cards

What is the 2# treatment of diabetes in pregnancy?

Preferred agent; add on if needed to achieve glycemic goals

None of the currently approved insulins cross the placenta (safety)

Reasonable delivery strategies → Multiple daily injections or Continuous subcutaneous injections (pump)

76
New cards

Oral antihyperglycemics in pregnancy?

Metformin and glyburide are options but are not recommended as first line agents for treatment

No other oral antihyperglycemics are considered safe during pregnancy

77
New cards

Glyburide in GDM?

Vs. metformin or insulin

Associated with higher rates of →

Neonatal hypoglycemia

Macrosomia (large birth weight)

Increased neonatal abdominal circumference

78
New cards

Metformin in GDM?

Lower risk of neonatal hypoglycemia (vs. insulin)

Less maternal weight gain (vs. insulin)

Should NOT be used in women with hypertension, preeclampsia, or those at risk for intrauterine growth restriction

79
New cards

Who should receive low-dose aspirin during pregnancy if they have preexisting Type 1 or Type 2 diabetes?

100–150 mg/day (162 mg is reasonable)

Start at 12–16 weeks gestation

80
New cards

When is someone with GDM a candidate for low-dose aspirin?

≥1 high-risk factor: chronic hypertension or autoimmune disease

Multiple moderate-risk factors → obesity, age ≥35, or no prior live birth